Legend Biotech Corp. (LEGN)
19.74
+0.70
(+3.68%)
USD |
NASDAQ |
Oct 15, 13:57
Legend Biotech Total Long Term Debt (Quarterly) : 121.80M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 121.80M |
| March 31, 2026 | 123.30M |
| December 31, 2025 | 94.60M |
| September 30, 2025 | 267.36M |
| June 30, 2025 | 387.92M |
| March 31, 2025 | 362.81M |
| December 31, 2024 | 350.60M |
| September 30, 2024 | 346.59M |
| June 30, 2024 | 338.93M |
| March 31, 2024 | 334.69M |
| December 31, 2023 | 328.67M |
| September 30, 2023 | 320.51M |
| June 30, 2023 | 318.62M |
| March 31, 2023 | 314.76M |
| Date | Value |
|---|---|
| December 31, 2022 | 284.53M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 195.72M |
| March 31, 2022 | 132.14M |
| December 31, 2021 | 122.97M |
| September 30, 2021 | 73.52M |
| June 30, 2021 | 20.11M |
| March 31, 2021 | 3.133M |
| December 31, 2020 | 3.373M |
| September 30, 2020 | 3.988M |
| June 30, 2020 | 3.433M |
| March 31, 2020 | 155.21M |
| December 31, 2019 | 6.085M |
| September 30, 2019 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 26.25B |
| Ionis Pharmaceuticals, Inc. | 2.189B |
| Johnson & Johnson | 0.00 |
| Arbutus Biopharma Corp. | 3.111M |
| Capricor Therapeutics, Inc. | 89.56M |